House, Senate Advance Bills Addressing Recalcitrant Cancer
September 21, 2012—The House Sept. 19 approved by voice vote legislation requiring the National Cancer Institute to establish individual scientific frameworks to address recalcitrant cancers.
The chamber’s approval of the Recalcitrant Cancer Research Act of 2012 (H.R. 733) comes one week after the House Energy and Commerce Subcommittee on Health amended the bill to broaden its scope from an exclusive focus on pancreatic cancer [see Washington Highlights, Sept. 14].
Meanwhile, the Senate Health, Education, Labor, and Pensions (HELP) Committee approved similar legislation in draft form the same day.
Also approved by voice vote, HELP Chair Tom Harkin (D-Iowa) noted that the bill would help “focus research on addressing the rarest and deadliest cancers.” Ranking Member Mike Enzi (R-Wyo.) concurred that the “frameworks provided for in the bill will hopefully bring new understanding of the mechanisms of disease and aid in the development of better screening and improve treatments.”
Director, Government Relations
Washington Highlights, a weekly electronic newsletter, features brief updates on the latest legislative and regulatory activities affecting medical schools and teaching hospitals.
For More Information
Senior Director, Government Relations